How Medical Affairs Impact the Pharmaceutical Industry
Ketamine and ECT Equally Effective for Treatment-Resistant Depression
High Prescription Drug Costs Lead Older Patients to Ration Medication
Researchers Explore Ozempic as a Potential Addiction Treatment
FTC’s Lawsuit Against Amgen Horizon Deal to Reach Court in September
FDA Approves New Opioid Reversal Nasal Spray, A Harm Reduction Tool
FDA Approves Abbvie’s Medication for Crohn’s Disease in Adults
CDC Update Identifies Fourth Death Linked to Eyedrop Recall
Promising Results Seen in Pancreatic Cancer mRNA Vaccine Trials
NIH Researchers Begin Clinical Trials on a Universal Influenza Vaccine
FDA Advisory Committee Favors Approval of Intranasal Epinephrine
FDA Finalizes Blood Donation Guidelines, Expands Eligibility
Syphilis Rates Continue to Rise as Penicillin Availability Falls
FDA Advisory Panel Favors Over-the-Counter Birth Control Pill: Opill
Department of Agriculture Licenses Lyme Vaccine for Use in Wild Mice
WHO Updates HPV Vaccine Guidelines: Shift Toward Single Dose Series
Lilly Announces Mounjaro’s Weight Loss Success in Recent Clinical Trial
Comparing Small Molecule and Biologics Drug Development Challenges
Sleeping Pills Linked to Lower Levels of Alzheimer’s Disease Proteins
A Melatonin Study Highlights a Lack of Supplement Regulation
GSK Secures First FDA Approval for an RSV Vaccine for Older Adults
FDA Publishes Draft Guidance for Decentralized Clinical Trials
How Do NIH Funding Requirements Impact Researcher Demographics?
Research Reveals That Forever Chemicals May Be Linked to Weight Gain